SAVOR-TIMI 53

Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the DPP-4 inhibitor saxagliptin

Top

Raz I, Bhatt DL, Hirshberg B, et al. Incidence of pancreatitis and pancreatic cancer in a randomized controlled multicenter trial (SAVOR-TIMI 53) of the dipeptidyl-peptidase-4 (DPP-4) inhibitor saxagliptin. Diabetes Care. 2014. DOI:10.2337/dc13-2546.